Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 383,314 | reported | 29 Dec 2025 | tx 95+1,197,709−587,633 |
| THOMPSON DESIGNS INC | 360,000 | reported | 12 Jun 2019 | tx 3+7,860,000 |
| NEXMED INC | 267,948 | reported | 06 Oct 2009 | tx 12+239,748 |
| ZEVRA THERAPEUTICS, INC. | 10,835 | reported | 09 Mar 2023 | tx 19+173,372 |
| BIOJECT MEDICAL TECHNOLOGIES INC | 0 | reported | 30 Apr 2014 | tx 17+445,334−156,400 |
| Valera Pharmaceuticals Inc | 0 | reported | 17 Apr 2007 | tx 11+146,500−609,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,334 | — | |
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,334 | 0.00 USD | deriv |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,413 | — | |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,413 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | — | |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 18,115 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5,468 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | 0.00 USD | deriv |
| 27 Aug 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 26,000 | 20.20 USD | |
| 27 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 2.24 USD | |
| 27 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 0.00 USD | deriv |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4,000 | — | |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 27 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,333 | — | |
| 27 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,333 | 0.00 USD | deriv |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,413 | — | |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,413 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 23,248 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 2,841 | 0.00 USD | deriv |
| 21 Aug 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 15,000 | 20.10 USD | |
| 21 Aug 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 15,000 | 4.01 USD | |
| 22 Aug 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 08 Apr 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 25,000 | 15.68 USD | |
| 08 Apr 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 25,000 | 4.01 USD | |
| 08 Apr 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 25,000 | 0.00 USD | deriv |
8 purchases reported after at least 12 months of silence — most recent on 30 Nov 2021.